R
9.56
0.03 (0.31%)
| Penutupan Terdahulu | 9.53 |
| Buka | 9.75 |
| Jumlah Dagangan | 1,215,411 |
| Purata Dagangan (3B) | 1,452,357 |
| Modal Pasaran | 886,475,264 |
| Harga / Buku (P/B) | 6.12 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 6 Nov 2025 |
| EPS Cair (TTM) | -1.16 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 2.15% |
| Nisbah Semasa (MRQ) | 8.43 |
| Aliran Tunai Operasi (OCF TTM) | -65.60 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -37.81 M |
| Pulangan Atas Aset (ROA TTM) | -52.85% |
| Pulangan Atas Ekuiti (ROE TTM) | -95.16% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Rezolute, Inc. | Menaik | Menaik |
AISkor Stockmoo
-0.3
| Konsensus Penganalisis | 4.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -4.5 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | -0.5 |
| Purata | -0.25 |
|
Rezolute Inc is a biopharmaceutical company. The company develops novel, sustained-release injectable therapies. It applies proprietary formulation and manufacturing capabilities to known, well-characterized molecules to create differentiated, patent-protected therapies that have the potential to significantly improve existing standards of care. Its pipeline products include RZ358 and RZ402. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Value |
| % Dimiliki oleh Orang Dalam | 9.65% |
| % Dimiliki oleh Institusi | 52.00% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Caxton Corp | 30 Sep 2025 | 1,986,818 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 20.00 (Maxim Group, 109.21%) | Beli |
| Median | 17.00 (77.82%) | |
| Rendah | 15.00 (Guggenheim, 56.90%) | Beli |
| Purata | 17.25 (80.44%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 8.76 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 20 Nov 2025 | 17.00 (77.82%) | Beli | 9.65 |
| 18 Sep 2025 | 17.00 (77.82%) | Beli | 8.20 | |
| Citizens | 29 Oct 2025 | 17.00 (77.82%) | Beli | 9.53 |
| Guggenheim | 22 Sep 2025 | 15.00 (56.90%) | Beli | 8.14 |
| Maxim Group | 19 Sep 2025 | 20.00 (109.21%) | Beli | 7.70 |
Tiada data dalam julat masa ini.
| Tarikh | Jenis | Butiran |
|---|---|---|
| 10 Nov 2025 | Pengumuman | Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 06 Nov 2025 | Pengumuman | Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update |
| 05 Nov 2025 | Pengumuman | Rezolute to Host Virtual Investor Event on Ersodetug Development Program |
| 15 Oct 2025 | Pengumuman | Rezolute to Participate in Upcoming Investor Conferences |
| 09 Oct 2025 | Pengumuman | Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) |
| 17 Sep 2025 | Pengumuman | Rezolute Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results and Provides Business Update |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |